4 completed, 1 active not recruiting, 1 withdrawn. 4 Phase 2, 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Active not recruiting 1, Withdrawn 1 |
| Phase 1 | 3 | Completed 2, Withdrawn 1 |
Follow hepalatide: new trials by email Literature Review of hepalatide trials Research Report on hepalatide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Access the Efficacy in Type 2 Diabetes Mellitus on Stable Metformin hepalatide - Type 2 Diabetes Patients | Phase 1 / Phase 2 | Withdrawn | Shanghai HEP Pharmaceutical Co., Ltd. | 2025-12-01 | 2023-12-08 | |
| A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis D hepalatide - Hepatitis D | Phase 2 | Active not recruiting | Shanghai HEP Pharmaceutical Co., Ltd. | 90 | 2024-12-11 | 2025-12-23 |
| Study of Hepalatide in Chronic Hepatitis D(CHD) Patients Hepalatide, Hepalatide Placebo - Chronic Hepatitis D Infection | Phase 2 | Completed | Shanghai HEP Pharmaceutical Co., Ltd. | 23 | 2023-10-07 | 2024-04-24 |
| A Study of Hepalatide Combined With TAF and PEG-IFN as Finite Treatment of Chronic Hepatitis B Patients Hepalatide, Placebo of Hepalatide, Tenofovir Alafenamide Tablets - Chronic Hepatitis B | Phase 2 | Completed | Shanghai HEP Pharmaceutical Co., Ltd. | 8 | 2022-08-23 | 2024-07-15 |
| Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers Hepalatide, Placebo - Hepatitis B， Chronic | Phase 1 | Completed | Shanghai HEP Pharmaceutical Co., Ltd. | 35 | 2016-08-01 | 2017-01-23 |
| Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers Hepalatide, Placebo - Hepatitis B， Chronic | Phase 1 | Completed | Shanghai HEP Pharmaceutical Co., Ltd. | 48 | 2015-10-01 | 2017-02-14 |
Hepatitis B, Chronic (3) · Hepatitis D (1) · Hepatitis D, Chronic (1)
Shanghai HEP Pharmaceutical Co., Ltd. (6)
China (4) · Mongolia (2)
Junqi Niu (1) · Oyunbileg Janchiv (1) · Qin Zhang (1)